News & Updates

Ventricular tachycardia predicts all-cause death and non-sudden cardiovascular death (NSCVD) in patients with non-ischaemic cardiomyopathy, a study suggests.

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia (V-tach) within 6 months following discharge compared with matched controls without severe infection in a Swedish case-control study presented at EHRA 2023.

Increased sodium intake is associated with increased coronary and carotid atherosclerosis burden in the general Swedish population, even in normotensive individuals and those without known cardiovascular disease (CVD), the SCAPIS* study finds.

Endometriosis appears to be associated with a significantly elevated risk of cardiovascular disease (CVD), specifically ischaemic heart disease and cerebrovascular disease, as suggested in a study.

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) tends to elevate the risk of first-time hospitalization for heart failure (HF) in patients with type 2 diabetes mellitus (T2DM), a study has shown. In addition, those with advanced age, elevated haemoglobin (Hb) A1c levels, and new users are particularly at higher risk.

The angiotensin receptor neprilysin inhibitor sacubitril/valsartan, used for heart failure, appears to have potent effects on 24‐hour blood pressure (BP) in Japanese patients with mild‐to‐moderate hypertension and in the subgroup of those with nondipping BP pattern, as shown in a study.

Eating at least 1.5 servings of fish each week does not appear to improve cardiovascular (CV) outcomes, reports a recent study, noting that its potential benefit must not be ruled out completely.